News & Events
News & Events
News
June 21, 2013
CiRA starts distribution of disease-specific iPS cells
CiRA has started to provide the following disease-specific iPS cells through RIKEN BioResource center (RIKEN BRC).
Three (3) lines of CINCA (chronic infantile neurological cutaneous and articular) syndrome patient-derived iPS cellsFive (5) lines of ALS (amyotrophic lateral sclerosis) patient-derived iPS cells
These cell lines are available for non-profit organizations for the purpose of academic research. Some of them, however, are available for profit-making organizations under some conditions.
The total of eight cell lines is provided through RIKEN BRC at present. When new lines of disease-specific iPS cells become available, it will be notified on the CiRA website;
for non-profit organizations / for for-profit organizations.
for non-profit organizations / for for-profit organizations.
Title and authors of the papers
Tanaka T, Saito MK et al. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. Blood. 9 August 2012
Egawa N, Inoue H et al. Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells. Science Translational Medicine 1 August 2012
